SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales slipped to Rs. 3469.50 millions for the September 2024 quarter as against Rs. 4252.40 millions during the year-ago period.The Total Profit for the quarter ended September 2024 of Rs. 80.20 millions grew from Rs.-152.60 millionsOperating Profit saw a handsome growth to 616.40 millions from 389.00 millions in the quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 3469.50 4252.40 -18.41 7104.40 7775.50 -8.63 12889.20 14438.10 -10.73
Other Income 3.20 12.30 -73.98 17.00 33.00 -48.48 53.70 221.40 -75.75
PBIDT 616.40 389.00 58.46 1052.60 601.10 75.11 -896.90 1561.80 -157.43
Interest 282.80 244.70 15.57 591.50 499.80 18.35 1059.70 900.60 17.67
PBDT 333.60 108.80 206.62 461.10 65.80 600.76 -3853.00 661.20 -682.73
Depreciation 253.40 261.40 -3.06 504.10 519.70 -3.00 1030.30 1109.00 -7.10
PBT 80.20 -152.60 -152.56 -43.00 -453.90 -90.53 -4883.30 -447.80 990.51
TAX 0.00 0.00 0.00 0.00 -102.50 0.00 785.40 -225.70 -447.98
Deferred Tax 0.00 0.00 0.00 0.00 -102.50 0.00 785.40 -224.60 -449.69
PAT 80.20 -152.60 -152.56 -43.00 -351.40 -87.76 -5668.70 -222.10 2452.32
Equity 402.10 360.00 11.69 402.10 360.00 11.69 360.00 360.00 0.00
PBIDTM(%) 17.77 9.15 94.21 14.82 7.73 91.65 -6.96 10.82 -164.33

Solara Active Pharma Share Price

489.30 -4.40 (-0.89%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×